Digital Cognitive-Motor Occupational Training with QEEG Monitoring in Schizophrenia Rehabilitation: An Exploratory Neurofunctional Study.
Supalak Khemthong, Maliwan Rueankam, Winai Chatthong
Adding real-time brain monitoring to a digital occupational task lowered engagement scores across all four activity domains in 30 people with schizophrenia.
The brain-activity patterns were descriptive only, with no inferential comparisons made. This is exploratory, not evidence the monitoring helps.
Key findings
1Engagement intensity scores were higher in the unmonitored condition than the monitored condition across all four activity domains (reward-related p = 0.013, emotion-regulation p = 0.011, social-affiliation p = 0.022, pleasure-oriented p = 0.012), meaning the monitoring reduced engagement rather than enhancing it.
2No inferential statistical comparisons were conducted across the QEEG index types (theta relative power, theta/beta ratio, beta relative power) because of differences in measurement scale; the regional brain-activity patterns reported are descriptive only.
3The four activity domains labelled with neurotransmitter names (dopamine, oxytocin, serotonin, endorphin) are explicitly described as a structural heuristic for task organisation, not a neurochemical classification, and the authors state the study does not assume direct neurochemical specificity.
Still to come
How it was doneWhat they foundWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Thirty participants, all from one Thai outpatient setting, with no mention of randomisation or counterbalancing of the two task conditions. The QEEG findings are purely descriptive; no inferential comparisons were made across the three index types (theta power, beta power, theta/beta ratio) because of scale differences, so the regional patterns cannot be statistically confirmed. Individual alpha peak frequency was not controlled for, which the authors acknowledge can shift the effective theta and beta band boundaries and inflate inter-individual variability. Standard deviations on engagement scores were large (up to 15.31 percentage points), reflecting the clinical heterogeneity of the schizophrenia sample and limiting the precision of any group-level comparison. The four activity domains are labelled with neurotransmitter names (dopamine, oxytocin, serotonin, endorphin) but are explicitly a structural heuristic for task organisation, not a neurochemical classification; the correlations between QEEG features and these domains should not be read as evidence of specific neurotransmitter effects. The study is explicitly exploratory; the authors state the findings are neurofunctional indicators, not validated digital biomarkers, and call for larger longitudinal studies before any clinical application.
Declared interests
Funded by the Electricity Generating Authority of Thailand (EGAT). The authors declare no competing interests. EGAT is a state-owned electricity utility and has no apparent commercial stake in the B2B application or BMP monitoring system.
The easy way to misread this
Do not read the moderate correlations between QEEG features and the four activity domains as evidence that specific brain regions or frequency bands drive reward, social bonding, emotion regulation, or pleasure in schizophrenia. The paper states repeatedly that the neurotransmitter-labelled domains are a structural heuristic for organising tasks, not a neurochemical model, and that the correlations are exploratory associations in 30 people, not validated biomarkers. Equally, do not read the lower engagement scores under monitoring as proof that QEEG monitoring is harmful; the authors note it may reflect increased cognitive effort that could support longer-term learning, though they do not demonstrate that benefit.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →